Formulary Interface Group

The formulary is managed by the South & West Devon Formulary Interface Group (FIG):

  • Dr Andrew Gunatilleke (Chair)
  • Dr Andy Craig
  • Dr Jamie Fulton
  • Mrs Emma Gitsham
  • Ms Phillipa Hawkins
  • Mr Matt Howard
  • Mr Paul Manson
  • Mrs Sarah Marner
  • Ms Sally Mayell
  • Dr Philip Melluish
  • Mrs Elena Mercer
  • Mr Jeremy Morris
  • Dr William Nolan
  • Mr Iain Roberts
  • Mr Mark Stone
  • Mr Christopher Sullivan
  • Mrs Larissa Sullivan
  • Dr Wayne Thomas
  • Mr Darren Wright

See below for the minutes from the South and West Devon Formulary Interface Group meetings:

Terms of reference (amended June 2015)

Purpose of the Group

To provide a forum for the Northern, Eastern and Western Devon Clinical Commissioning Group (NEW Devon CCG) and the South Devon and Torbay Clinical Commissioning Group (SD&T CCG) to work with the provider trusts it commissions to incorporate national and local treatment choices and guidance into a Joint Formulary.

Functions

The South and West Devon Formulary Interface Group (FIG) will:

  • Produce, maintain and review a formulary for use across South and West Devon. The formulary will comprise the output of processes to support the managed introduction, utilisation and withdrawal of treatments within the local health economy.
  • Ensure treatments approved by local decision making groups are included in the South and West Devon Joint Formulary. Local decision making groups include:
    • Devon Clinical Policy Committee
    • South Devon Healthcare NHS Foundation Trust Drugs & Therapeutics Committee
    • Plymouth Hospitals NHS Trust Drugs & Therapeutics Committee
  • Ensure treatments recommended by a NICE Technology Appraisal are included in the South and West Devon Joint Formulary within 90 days of publication.
  • Support secondary care use of drugs commissioned by NHS England.
  • Adopt treatment focused care pathways and develop formulary guidance to support the safe and appropriate use of treatments included in the formulary.
  • Engage with local specialists, generalists, clinical groups and networks to ensure guidance is clinically appropriate and locally relevant.
  • Review and update the Joint Formulary according to an agreed work plan, which will be guided by national clinical guidance, new drug technologies and consultation with local clinicians.
  • Receive drugs safety update information and consider how this information should be reflected in the formulary.
  • Support cost-effective, evidence-based prescribing in line with the stated strategies and visions of NEW CCG and SD&T CCG.

Membership

The South and West Formulary Interface Group is a multi-stakeholder group whose membership is intended to reflect the needs of the localities and organisations involved. A suggested core membership is:

  • Clinical Chair
  • Deputy Clinical Chair
  • GP representation, Western locality of NEW Devon CCG
  • GP representation, SD&T CCG
  • Consultant representation, South Devon Healthcare NHS Foundation Trust
  • Consultant representation, Plymouth Hospitals NHS Trust
  • Pharmacy representation, South Devon Healthcare NHS Foundation Trust
  • Pharmacy representation, Plymouth Hospitals NHS Trust
  • Clinical Effectiveness Medicines Optimisation (CEMO) Pharmacist representation from the Western locality of NEW Devon CCG
  • Medicines Optimisation Team Pharmacist representation from SD&T CCG
  • Pharmacist representative, Plymouth Community Healthcare
  • Pharmacist representative, Devon partnership Trust
  • Pharmacist representative, Kernow Clinical Commissioning Group
  • Nurse / Non-medical prescriber representative, Plymouth Community Health Care
  • Lay member
  • Joint Formularies Pharmacist, NEW Devon CCG
  • Joint Formularies Technician, NEW Devon CCG
  • Clinical Evidence Manager, NEW Devon CCG

Clinical specialists and other stakeholders can be invited to attend relevant meetings.

Meetings and conduct of business

Meetings will be conducted regularly at a frequency agreed by the group. Meetings of the Group will be formal and appropriate agenda and minutes produced.

Meetings may be attended in person or via teleconferencing where services exist. Administrative support will be provided by the Clinical Effectiveness Team, NEW Devon CCG.

For the Group to be quorate there will be at least two medical practitioners (of whom at least one is a General Practitioner) and one pharmacist representative from the CEMO Team, NEW Devon CCG or Medicines Optimisation Team, SD&T CCG.

Governance and reporting arrangements

The South and West Devon Formulary Interface Group will provide progress reports for the Clinical Policy Committee. This group reports to the Clinical Commissioning Group Boards.

Minutes of the South and West Devon Formulary Interface Group will be made available on the Joint Formulary website.

The Terms of Reference will be reviewed annually and available on the Joint Formulary website.

Declaration of Interests

All members of the committee and attendees will be expected to complete a declaration of interest. The Chair will ask that declarations of interest are made known to the committee members to indicate any issues where there is a personal competing interest whether financial, academic or research. These are then noted in the minutes of the appropriate meeting.

South & West Devon FIG Minutes 2017

South & West Devon FIG Minutes 2016

South & West Devon FIG Minutes 2015

South & West Devon FIG Minutes 2014

South & West Devon FIG Minutes 2013

 

Home > Formulary > Committee

 

  • First line
  • Second line
  • Specialist
  • Hospital